PTC is committed to bringing hope to patients with rare and genetic diseases.
Our scientists are finding new ways to regulate biology to control disease.
We are developing new treatments for Duchenne Muscular Dystrophy, Cystic Fibrosis and other diseases.
Translating Science. Transforming Lives.
View Our Pipeline
Careers at PTC
PTC STRIVE Awards Program
PTC team runs NYC Marathon to support Duchenne muscular dystrophy
PTC Completes Enrollment of Phase 3 Clinical Trial of Translarna™ for Patients with Cystic Fibrosis
PTC Therapeutics Reports Third Quarter 2015 Financial Results, Provides Corporate Update and Reviews Key Findings from ACT DMD
PTC Therapeutics to Participate at Upcoming Investor Conferences
View all latest news